Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abcellera Biologics Inc
(NQ:
ABCL
)
2.610
-0.010 (-0.38%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abcellera Biologics Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Why AbCellera Biologics Stock Jumped 19.4% Last Month
October 07, 2021
Despite last month's gains, the biotech stock is now down roughly 61% year to date.
Via
The Motley Fool
AbCellera, Everest Medicines Team Up To Develop 10 Therapeutic Antibodies
September 23, 2021
AbCellera Biologics Inc (NASDAQ: ABCL) and Everest Medicines Limited have entered into a multi-year collaboration and license agreement to discover...
Via
Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
September 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 22) Acceleron Pharma Inc. (...
Via
Benzinga
Exposures
COVID-19
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Exposures
Product Safety
Analyzing AbCellera Biologics's Unusual Options Activity
August 03, 2021
Shares of AbCellera Biologics (NASDAQ:ABCL) saw some unus...
Via
Benzinga
Cramer's Advice On Ulta Beauty, Laredo Petroleum And More
September 23, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer advised a viewer to buy more Ulta Beauty Inc (NASDAQ: ULTA). He likes the stock very much. Cramer doesn't like...
Via
Benzinga
AbCellera and Everest Medicines Announce Multi-Target Collaboration to Advance New Antibody Therapies
September 22, 2021
From
AbCellera Biologics Inc.
Via
Business Wire
A Day Of Huge Market Moves
September 21, 2021
It was a day of huge market moves and several reporting companies. Trudeau won but did not get a parliamentary majority.
Via
Talk Markets
Lilly to Supply the EU and EEA with up to 220,000 Doses of AbCellera-Discovered Bamlanivimab Together with Etesevimab for the Treatment of Confirmed COVID-19
September 21, 2021
From
AbCellera Biologics Inc.
Via
Business Wire
15 Stocks Moving in Friday's Pre-Market Session
September 17, 2021
Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) rose 42% to $3.21 in pre-market trading. AbCellera Biologics Inc. (NASDAQ: ABCL) rose 18% to $23.35 in pre-market trading....
Via
Benzinga
AbCellera Stock Is Moving Higher After Expanded Use Nod For Lilly-Partnered COVID-19 Antibody
September 17, 2021
The FDA has expanded the Emergency Use Authorization (EUA) for bamlanivimab 700 mg and etesevimab 1400 mg administered together to include post-exposure prophylaxis in...
Via
Benzinga
Exposures
COVID-19
Product Safety
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
September 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Bicycle Therapeutics plc (...
Via
Benzinga
Emergency Use Authorization of AbCellera-Discovered Bamlanivimab Administered with Etesevimab Expanded by the FDA to Include Post-Exposure Prophylaxis for the Prevention of COVID-19
September 16, 2021
From
AbCellera Biologics Inc.
Via
Business Wire
Why AbCellera Biologics Stock Jumped 7% on Wednesday
September 15, 2021
The company's drug-development technology is starting to attract attention.
Via
The Motley Fool
Exposures
COVID-19
AbCellera Shares Are Moving Higher On Licensing Pact With Moderna
September 15, 2021
AbCellera Biologics Inc (NASDAQ: ABCL) has entered into a research collaboration and license agreement with Moderna Inc (NASDAQ: MRNA) for antibodies for...
Via
Benzinga
AbCellera Announces Collaboration with Moderna to Discover Therapeutic Antibodies for mRNA Medicines
September 15, 2021
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera Acquires TetraGenetics, Enhancing Capabilities to Generate Antibodies Against High-Value Targets
September 13, 2021
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera to Present Virtually at the BofA Securities – Tech Solutions for Drug Discovery Conference
September 10, 2021
From
AbCellera
Via
Business Wire
A Weak Week
September 10, 2021
Chinese car-maker Nio appears to have been able to weather the Beijing crackdown on foreign listed firms better than later entrants.
Via
Talk Markets
Here's Why AbCellera Biologics Stock Gained 10.6% Last Month
September 04, 2021
Even with its recent gains, the biotech stock is down roughly 53.4% in 2021's trading.
Via
The Motley Fool
Why AbCellera Biologics Stock Was Up More Than 17% on Friday
August 13, 2021
The biopharma company's second quarter was better than expected. The future looks pretty bright, too.
Via
The Motley Fool
78 Biggest Movers From Friday
August 16, 2021
Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering. Flora Growth...
Via
Benzinga
AbCellera Biologics Inc. (ABCL) Q2 2021 Earnings Call Transcript
August 13, 2021
ABCL earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
53 Stocks Moving In Friday's Mid-Day Session
August 13, 2021
Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares climbed 30.9% to $0.8270 after the company reported better-than-expected Q2 sales. The company said it continues to experience demand...
Via
Benzinga
AbCellera Reports Q2 2021 Business Results
August 12, 2021
From
AbCellera Biologics Inc.
Via
Business Wire
More Greek Variants To Follow
August 12, 2021
Nokia will supply the Western Power District with private long-term evolution fast 5G grid for trials.
Via
Talk Markets
Is It Time to Buy 5 of the Nasdaq's Worst-Performing Stocks of 2021?
August 12, 2021
One particular group of stocks is overrepresented among the exchange's biggest losers this year. That's an important detail.
Via
The Motley Fool
Billionaire Masayoshi Son's SoftBank Claims $5B Stake In Roche: Bloomberg
August 04, 2021
SoftBank Group Corp (OTC: SFTBF) has quietly acquired a $5 billion stake in Roche Holdings AG (OTC: RHHBF), making it one of the largest investors of the Roche,...
Via
Benzinga
EQRx and AbCellera Announce Collaboration to Accelerate the Advancement of New Innovative Medicines
August 04, 2021
From
AbCellera Biologics Inc.
Via
Business Wire
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
August 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.